Prestige Consumer Healthcare logo

Prestige Consumer HealthcareNYSE: PBH

Profile

Sector:

Healthcare

Country:

United States

IPO:

10 February 2005

Next earnings report:

07 November 2024

Last dividends:

27 September 2018

Next dividends:

N/A
$3.67 B
-1%vs. 3y high
87%vs. sector
-1%vs. 3y high
31%vs. sector
-6%vs. 3y high
59%vs. sector
-1%vs. 3y high
49%vs. sector

Price

after hours | Fri, 01 Nov 2024 20:02:53 GMT
$74.05-$0.70(-0.94%)

Dividend

No data over the past 3 years
$267.14 M$282.15 M
$267.14 M$49.07 M

Analysts recommendations

Institutional Ownership

PBH Latest News

What Makes Prestige Consumer Healthcare (PBH) a Good Fit for 'Trend Investing'
zacks.com20 September 2024 Sentiment: POSITIVE

Prestige Consumer Healthcare (PBH) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.

PBH or SYK: Which Is the Better Value Stock Right Now?
zacks.com04 September 2024 Sentiment: POSITIVE

Investors interested in Medical - Products stocks are likely familiar with Prestige Consumer Healthcare (PBH) and Stryker (SYK). But which of these two stocks offers value investors a better bang for their buck right now?

Prestige Consumer Healthcare Inc. Reports First Quarter Fiscal 2025 Results
globenewswire.com08 August 2024 Sentiment: NEUTRAL

TARRYTOWN, N.Y., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its first quarter ended June 30, 2024.

Prestige Consumer Healthcare to Release Fiscal 2025 First Quarter Earnings Results
globenewswire.com02 July 2024 Sentiment: POSITIVE

TARRYTOWN, N.Y., July 02, 2024 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2025 first quarter earnings release on Thursday, August 8, 2024 before the opening of the market. The Company will host a conference call to discuss the results that same morning at 8:30 a.m. ET.

Prestige Consumer (PBH) Q4 Earnings Miss, Operating Margin Falls
zacks.com16 May 2024 Sentiment: NEGATIVE

Prestige Consumer's (PBH) Q4 performance is negatively affected by supply chain challenges, leading to difficulties in meeting retailer demand.

Prestige Consumer Healthcare (PBH) Reports Q4 Earnings: What Key Metrics Have to Say
Zacks Investment Research14 May 2024 Sentiment: POSITIVE

While the revenue and EPS of Prestige Consumer Healthcare (PBH) provide insight into its quarterly performance ending in March 2024, it may be beneficial to also analyze how certain important metrics stack up against Wall Street predictions and figures from the previous year.

Prestige Consumer Healthcare (PBH) Misses Q4 Earnings and Revenue Estimates
Zacks Investment Research14 May 2024 Sentiment: NEGATIVE

Prestige Consumer Healthcare (PBH) reported quarterly earnings of $1.02 per share, falling short of the Zacks Consensus Estimate of $1.14 per share. This is lower than the earnings of $1.07 per share reported in the same quarter last year.

Here's Why You Should Retain Prestige Consumer (PBH) Stock Now
Zacks Investment Research19 April 2024 Sentiment: POSITIVE

Investors can look forward to strong performance from Prestige Consumer's (PBH) varied portfolio.

Here's Why Prestige Consumer Healthcare (PBH) is a Strong Value Stock
Zacks Investment Research08 April 2024 Sentiment: POSITIVE

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Prestige Consumer (PBH) Banks on its Portfolio Amid Cost Woes
Zacks Investment Research02 April 2024 Sentiment: POSITIVE

Prestige Consumer (PBH) develops long-term partnerships across its diverse retail footprint and invests heavily in the e-commerce channel.

  • 1(current)
  • 2

What type of business is Prestige Consumer Healthcare?

Prestige Consumer Healthcare Inc. is engaged in the production and distribution of over-the-counter medical products. The company has a wide range of medical products, including pain relievers, dermatological products, cold remedies, products for eye, ear, oral, gastrointestinal health, as well as products for women's health. The company's portfolio includes pain relief powders under the BC/Goody brand, Boudreaux's Butt Paste children's ointments, Chloraseptic sore throat lozenges, Clear Eyes products for reducing eye redness. In addition, the company offers wart removal products, earwax removal products, as well as enemas, stomach upset remedies, Monistat vaginal antifungal products and Nix lice and parasite treatments. The company was founded in 1996, with its headquarters located in Tarrytown, New York.

What sector is Prestige Consumer Healthcare in?

Prestige Consumer Healthcare is in the Healthcare sector

What industry is Prestige Consumer Healthcare in?

Prestige Consumer Healthcare is in the Drug Manufacturers - Specialty & Generic industry

What country is Prestige Consumer Healthcare from?

Prestige Consumer Healthcare is headquartered in United States

When did Prestige Consumer Healthcare go public?

Prestige Consumer Healthcare initial public offering (IPO) was on 10 February 2005

What is Prestige Consumer Healthcare website?

https://www.prestigebrands.com

Is Prestige Consumer Healthcare in the S&P 500?

No, Prestige Consumer Healthcare is not included in the S&P 500 index

Is Prestige Consumer Healthcare in the NASDAQ 100?

No, Prestige Consumer Healthcare is not included in the NASDAQ 100 index

Is Prestige Consumer Healthcare in the Dow Jones?

No, Prestige Consumer Healthcare is not included in the Dow Jones index

When was Prestige Consumer Healthcare the previous earnings report?

No data

When does Prestige Consumer Healthcare earnings report?

The next expected earnings date for Prestige Consumer Healthcare is 07 November 2024